echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Nutrition News > The Lancet Infectious Diseases: Threat of untreatable gonorrhea can be addressed with existing meningitis vaccine

    The Lancet Infectious Diseases: Threat of untreatable gonorrhea can be addressed with existing meningitis vaccine

    • Last Update: 2022-05-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Peer-reviewed/2 observational studies/1 modeling study/person

    • Three research papers identify effective ways to improve protection against gonorrhea infection amid rising cases and increased drug resistance


    • In a mass vaccination program in South Australia, an observational study of the effectiveness of the 4CMenB vaccine showed that two doses of the vaccine were 33% effective against gonorrhea in adolescents and young adults


    • During 2016-2018, an observational study of the health records of 16-23 year olds in New York City and Philadelphia, USA, showed that receiving two doses of the 4CMenB meningitis vaccine provided 40% protection against gonorrhea


    The findings of three related papers published in the journal The Lancet Infectious Diseases show that amid rising cases worldwide and increasing bacterial resistance to drugs used to treat gonorrhea , the meningitis vaccine may help improve the ability to prevent gonorrhea


    Professor Helen Marshall said: "While recent research has provided evidence that the 4CMenB vaccine is associated with a reduced risk of gonorrhea, the vaccine is only available to adolescents and young adults for a short period of time


    The authors acknowledge some limitations


    In a related review article, Prof.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.